Treatment of tardive dyskinesia with ceruletide
- 1 January 1988
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 12 (5) , 803-812
- https://doi.org/10.1016/0278-5846(88)90025-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long-lasting effect of systemically administrated caerulein on monoaminergic neuronal pathways in rat brainNeuropeptides, 1987
- Dopamine receptor elevation by cholecystokininPeptides, 1984
- The Effects of Ceruletide in SchizophreniaArchives of General Psychiatry, 1984
- Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidolEuropean Journal of Pharmacology, 1984
- Ceruletide: A New Drug for the Treatment of Schizophrenic Patients?Archives of General Psychiatry, 1984
- Coexistence of peptides and classical neurotransmittersTrends in Neurosciences, 1983
- Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Effect of a cholecystokinin preparation on brain monoamines in the rat.The Japanese Journal of Physiology, 1980
- Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesiaPsychopharmacology, 1974